Pharmaceutical Business Investment Opportunities

Nutraceutical manufacturing, tech marketing & sales company, based in Srebrenik, Bosnia. - Our products are nutraceutical supplements for common disease conditions such as, prostate, hemorrhoids, diabetes and hypertension weight loss and hair loss. - Planning to launch products for more disease conditions such as psoriasis and other skin conditions. - Our clients are individual customers from countries across Eastern Europe such as Serbia, Croatia, Romania etc. Planning to expand to other European countries as well. - We get about 3 to 4k orders every month. Average value of each product is EUR 75. - Manufacturing capacity is 70k products everyday. - Since its inception, the company has showcased significant financial growth, with revenues escalating from €700,000 in 2021 to €5 million last year, and anticipated revenue of around €6 to €7 million for this year. - Till date, we’ve successfully crossed over 45,000 orders, evidencing strong market engagement. - Our seasoned leadership team has been instrumental in nurturing valuable industry relationships. - Our innovative in-house SaaS projects have bolstered our operational prowess: our affiliate network; an ads tracking software; a call center software enhancing our sales processes and a website builder facilitating seamless online presence. - There are 98 permanent employees. Additionally, we have 200+ contract marketing partners. - The company has ISO, GMP, and MoH licenses.

Nutraceutical manufacturing, tech marketing & sales company, based in Srebrenik, Bosnia. - Our products are nutraceutical supplements for common disease conditions such as, prostate, hemorrhoids, diabetes and hypertension weight loss and hair loss. - Planning to launch products for more disease conditions such as psoriasis and other skin conditions. - Our clients are individual customers from countries across Eastern Europe such as Serbia, Croatia, Romania etc. Planning to expand to other European countries as well. - We get about 3 to 4k orders every month. Average value of each product is EUR 75. - Manufacturing capacity is 70k products everyday. - Since its inception, the company has showcased significant financial growth, with revenues escalating from €700,000 in 2021 to €5 million last year, and anticipated revenue of around €6 to €7 million for this year. - Till date, we’ve successfully crossed over 45,000 orders, evidencing strong market engagement. - Our seasoned leadership team has been instrumental in nurturing valuable industry relationships. - Our innovative in-house SaaS projects have bolstered our operational prowess: our affiliate network; an ads tracking software; a call center software enhancing our sales processes and a website builder facilitating seamless online presence. - There are 98 permanent employees. Additionally, we have 200+ contract marketing partners. - The company has ISO, GMP, and MoH licenses.

The two main partners sold their stake in a previous company almost 10 years back and have now created their own new company. - They hold over 40 patents and are on the verge of their first approved generic complex injectable drug in a couple of months. - The facility was inspected very recently by the FDA and passed. - We have 5 drugs pending approval with a total market value of over USD 4B and only a few competitors. - The company should be worth USD 2B in another 3 years. - The business has not generated any revenue because we have been in the process of R&D in developing these drugs for the past 6 years and have invested over USD 40 million in the business.

We are working with five clients. We are a research-based product development partner to pharmaceutical companies. Promoter experience: Promoter is a pharmaceutical professional with 18+ years of work experience (Formulation scientist) turned to healthcare entrepreneur. In 3 years, business will reach USD 2 million revenue per year. We signed up new clients this year and have already achieved INR 1 Cr for this year. More clients are in the pipeline. We generate almost equal revenue from fee for service model and in-house asset sale model.

Company specializing in distributing its own branded generic medicines. - We have over 12 different products. - Products are manufactured by a contract producer. - Planning to start our own manufacturing in the next 2 years. - Average ticket size is INR 100. - Our target clients are doctors and medical stores. - Have partnerships with 500+ clients. Clients/doctors prescribe our products regularly to patients. - Planning to launch IPO in the future. - Currently breaking even but aiming to start generating profits from next month. - We are currently focussing on growth and expanding to new regions. - Currently active in Gujarat, Rajasthan, and Maharashtra. - Business has a well-optimized website and software tools to run the business efficiently.

We specialize in manufacturing vegan liquid-filled capsules, as well as advanced dosage formats such as tablet-in-capsule and capsule-in-capsule, supported by stability data. - Our current manufacturing capacity stands at 3 crore tablets and 50 lakh capsules per month. - We are presently supplying to 80 clients and undertaking contract manufacturing in Uzbekistan, Philippines, Singapore, Australia, Ghana, Kuwait, Slovakia, Togo, and Tanzania. - In addition to contract manufacturing, we market products under our own brand names, with 4 products registered in Togo and 37 products registered in Tanzania, and plans underway to expand across the entire East African region. - We export merchandise to Mauritius, Nepal, Congo, and Dubai, and are in the final stages of signing MOUs for expansion into 20 additional countries. - The promoter brings 17 years of industry experience. - Our primary manufacturing facility operates from a leased shed of approximately 14,000 sq. ft. , with an additional 7,000 sq. ft. under expansion, and is being upgraded in compliance with export norms. - We also own a 5,450 sq. ft. unit (with 3,750 sq. ft. built-up area) dedicated to the manufacturing of Ayurvedic and cosmetic products. - Additionally, the company owns 57,800 sq. ft. of greenfield industrial land for future expansion.

• The business made total sales of INR 29.5+ lakh 2 years ago. Last financial year, we did total sales of INR 93.5+ lakh. And in the current financial year, our total sales stand at INR 1.29+ crores. We will make more than 1.40+ crores this financial year. • We are a GMP & ISO 9001:2015 certified pharma marketing company based in Kolkata, West Bengal. Our company was incorporated 4 years ago and we started operations mainly 3 years ago. • We have over 550+ doctors prescribing our medicines from our portfolio. We are focused on orthopaedics, gynaecologists, and physicians. We have served more than 3+ lakh patients. • We mainly operate in two states of Eastern India - West Bengal and Assam. • Our distributors and stockists network is organized effectively and efficiently. • We have medicines marketed and sold under our brand name, and we sell about 16 products (7 registered trademarks) as brands. • All of our medicine manufacturers are WHO, GMP & ISO certified. • We have an efficient and operational field force with NSM, RSM, ASM, TDE, MR, and TMR. • Our directors & managers have vast experience of about 30+ years. • The business has achieved extraordinary growth in a short period without any outside investments or external loans, and the entire credit for this success goes to the committed field force, managers, and management team. • The business is registered in Krishnanagar but we have a rented office in Kolkata & a virtual office in Mumbai. We mainly operate from Kolkata.